Clinical Trials Directory

Trials / Completed

CompletedNCT03287115

Biomarkers of Broccoli Intake: A Pilot Study

Biomarkers of Broccoli Intake: A Pilot Study to Characterize Novel Metabolites by Targeted Metabolic Profiling and Non-Targeted Metabolomics

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
USDA Beltsville Human Nutrition Research Center · Federal
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Accepted

Summary

The objectives of the study are 1) to characterize plasma and urinary metabolites that originate from glucobrassicin, 1-methoxyglucobrassicin, 4-methoxyglucobrassicin, and 4-hydroxyglucobrassicin, which are the major indole glucosinolates found in broccoli, and 2) to identify novel plasma and urinary metabolites following broccoli consumption that may have roles in reducing the risk of cancer.

Detailed description

Consumption of Brassica vegetables is inversely associated with incidence of several cancers, including cancer of the lung, stomach, liver, colon, rectum, breast, endometrium, and ovaries. Brassicas are a good source of many nutrients, but the unique characteristic of Brassicas is their rich content of glucosinolates. Breakdown products of indole glucosinolates in Brassica vegetables show promise for reducing the risk of cancer, but have received comparatively less research attention than those of aliphatic glucosinolates. The aim of this study is to investigate plasma and urinary metabolites of indole glucosinolates from broccoli and to identify novel metabolites that may have roles in reducing cancer risk.

Conditions

Interventions

TypeNameDescription
OTHERBroccoli consumptionAll subjects will eat broccoli on day 11

Timeline

Start date
2017-11-06
Primary completion
2017-11-17
Completion
2017-11-17
First posted
2017-09-19
Last updated
2017-11-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03287115. Inclusion in this directory is not an endorsement.

Biomarkers of Broccoli Intake: A Pilot Study (NCT03287115) · Clinical Trials Directory